The release only tells us that CR H bought back an unspecified number of ordinary shares on 13 August 2025; the exact share count and the price paid are omitted from the excerpt. Without the disclosed figure we cannot calculate the buy‑back’s weight against CR H’s total issued shares (≈ 1.2 billion ordinary shares) or its free‑float (roughly 70‑75 % of issued capital). The regulatory filing itself will list the “aggregate number of ordinary shares acquired,” which you can then express as a percentage of the current outstanding share count and, more meaningfully, as a percentage of the free‑float.
In practice, a buy‑back that reaches 1‑2 % of free‑float is generally viewed as a modest, confidence‑signalling move, while anything above 3‑4 % is sizable enough to lift the price‑to‑book premium and tighten the share‑price support zone. When the actual figure is released, compare it with the average daily volume (≈ 3‑4 million shares) to gauge execution pressure: a buy‑back representing less than 0.5 % of average daily volume will have little immediate market impact, whereas a larger, faster‑executed program can create short‑term upward bias and compress the bid‑ask spread.
Actionable take‑away: Monitor the SEC/UK Gazette filing for the precise share‑count figure. If the buy‑back is ≥ 2 % of free‑float, consider a short‑to‑medium‑term bullish bias on CR H, especially if the price is trading near its 50‑day moving average and technical indicators (RSI, MACD) are neutral‑to‑bullish. Conversely, if the size is minimal (< 0.5 % of free‑float), treat the announcement as a routine capital‑return move and keep any positioning aligned with the broader sector trend rather than the buy‑back itself.